OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
7181$1486.0059

Japan Post Insurance Co Ltd

Life & Health InsuranceVerified

Japan Post Insurance maintains a conservative capital structure with a debt-to-equity ratio of 0.12, indicating a low reliance on debt financing. The company's liquidity position is assessed as low, with a price-to-book ratio of 0.47 and a price-to-tangible-book ratio of 0.47, suggesting that the market values the company's equity at a discount to its book value. Despite a negative operating cash flow of -3.06 trillion JPY, the firm holds 1.197 trillion JPY in cash and equivalents, providing a buffer against short-term liquidity pressures. Profitability metrics reveal a muted performance, with a return on equity (ROE) of 0.64% and a return on assets (ROA) of 0.04%, both significantly below the industry median for life and health insurers. The company's net income of 21.9 billion JPY is supported by an operating income of 36.3 billion JPY, but the low ROE suggests inefficiencies in capital deployment or competitive pressures. Geographically, Japan Post Insurance is heavily concentrated in the Japanese domestic market, with no disclosed international operations. Segment-wise, the firm operates as a single business unit, with no material diversification across product lines or geographic regions. This concentration increases exposure to domestic economic and regulatory shifts. The company's growth trajectory is modest, with no disclosed revenue growth in the most recent fiscal year. Analysts project a mean price target of 1,683.33 JPY, implying a potential upside of 13.3% from the current market price of 1,486 JPY. However, the low ROE and weak cash flow generation suggest limited organic growth potential without strategic or operational improvements. Risk factors include the low liquidity rating and the potential for regulatory changes in the Japanese insurance sector. The firm's dilution risk is assessed as low, with no immediate filing-based flags detected. However, the company's capital expenditure of -86.5 billion JPY indicates ongoing investment in infrastructure or technology, which could impact short-term profitability. Recent events include the publication of the latest financial results, which show a stable but unremarkable performance. No material changes in management, strategy, or regulatory environment have been disclosed in the most recent filings.

30-day price · 7181(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyJapan Post Insurance Co Ltd
Ticker7181.T
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryLife & Health Insurance
AI analysis

Business. Japan Post Insurance Co Ltd provides life and health insurance services in Japan, generating revenue primarily through premium income and investment returns on its substantial asset base.

Classification. Japan Post Insurance is classified under the Financials sector, specifically in the Life & Health Insurance industry, with a high confidence level of 0.92 based on verified market data.

Japan Post Insurance maintains a conservative capital structure with a debt-to-equity ratio of 0.12, indicating a low reliance on debt financing. The company's liquidity position is assessed as low, with a price-to-book ratio of 0.47 and a price-to-tangible-book ratio of 0.47, suggesting that the market values the company's equity at a discount to its book value. Despite a negative operating cash flow of -3.06 trillion JPY, the firm holds 1.197 trillion JPY in cash and equivalents, providing a buffer against short-term liquidity pressures. Profitability metrics reveal a muted performance, with a return on equity (ROE) of 0.64% and a return on assets (ROA) of 0.04%, both significantly below the industry median for life and health insurers. The company's net income of 21.9 billion JPY is supported by an operating income of 36.3 billion JPY, but the low ROE suggests inefficiencies in capital deployment or competitive pressures. Geographically, Japan Post Insurance is heavily concentrated in the Japanese domestic market, with no disclosed international operations. Segment-wise, the firm operates as a single business unit, with no material diversification across product lines or geographic regions. This concentration increases exposure to domestic economic and regulatory shifts. The company's growth trajectory is modest, with no disclosed revenue growth in the most recent fiscal year. Analysts project a mean price target of 1,683.33 JPY, implying a potential upside of 13.3% from the current market price of 1,486 JPY. However, the low ROE and weak cash flow generation suggest limited organic growth potential without strategic or operational improvements. Risk factors include the low liquidity rating and the potential for regulatory changes in the Japanese insurance sector. The firm's dilution risk is assessed as low, with no immediate filing-based flags detected. However, the company's capital expenditure of -86.5 billion JPY indicates ongoing investment in infrastructure or technology, which could impact short-term profitability. Recent events include the publication of the latest financial results, which show a stable but unremarkable performance. No material changes in management, strategy, or regulatory environment have been disclosed in the most recent filings.
Key takeaways
  • Japan Post Insurance has a low debt-to-equity ratio of 0.12, indicating a conservative capital structure.
  • The company's ROE of 0.64% is significantly below the industry median, suggesting inefficiencies in capital use.
  • The firm is geographically and operationally concentrated in Japan, increasing exposure to domestic economic and regulatory risks.
  • Analysts project a mean price target of 1,683.33 JPY, implying a potential upside of 13.3% from the current market price.
  • The company's liquidity position is assessed as low, with a price-to-book ratio of 0.47.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue
Gross profit
Operating income$36.29B
Net income$21.90B
R&D
SG&A
D&A
SBC
Operating cash flow-$3.06T
CapEx-$86.53B
Free cash flow
Total assets$60.86T
Total liabilities$57.46T
Total equity$3.40T
Cash & equivalents$1.20T
Long-term debt$405.86B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$299.26B$166.10B$171.78B
FY-3$288.32B$158.06B$122.30B
FY-2$200.22B$97.61B$68.98B
FY-1$177.33B$87.06B$6.12B
FY0$214.16B$123.47B$66.91B
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$70.17T$2.84T$1.47T
FY-3$67.17T$2.42T$1.31T
FY-2$62.69T$2.38T$1.48T
FY-1$60.86T$3.40T$1.20T
FY0$59.56T$3.24T$2.01T
PeriodOCFCapExFCFSBC
FY-4-$2.81T-$32.33B$171.78B
FY-3-$2.76T-$29.66B$122.30B
FY-2-$2.98T-$32.24B$68.98B
FY-1-$3.06T-$86.53B$6.12B
FY0-$1.63T-$57.75B$66.91B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$36.29B$21.90B
FQ-6$46.78B$20.95B
FQ-5$99.62B$41.94B
FQ-4$46.37B$21.54B
FQ-3$21.40B$39.04B
FQ-2$84.15B$34.65B
FQ-1$126.08B$59.21B
FQ0$66.37B$24.55B
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$60.86T$3.40T$1.20T
FQ-6$60.94T$3.47T$1.37T
FQ-5$60.77T$3.30T$1.68T
FQ-4$60.47T$3.49T$1.48T
FQ-3$59.56T$3.24T$2.01T
FQ-2$58.93T$3.38T$1.53T
FQ-1$58.99T$3.80T$1.75T
FQ0$58.98T$4.12T$1.54T
PeriodOCFCapExFCFSBC
FQ-7-$3.06T-$86.53B
FQ-6
FQ-5-$272.56B-$32.77B
FQ-4
FQ-3-$1.63T-$57.75B
FQ-2
FQ-1-$941.87B-$23.72B
FQ0
Valuation
Market price$1486.00
Market cap$1.61T
Enterprise value$818.79B
P/E73.5
Reported non-GAAP P/E
EV/Revenue
EV/Op income22.6
EV/OCF
P/B0.5
P/Tangible book0.5
Tangible book$3.40T
Net cash$791.46B
Current ratio
Debt/Equity0.1
ROA0.0%
ROE0.6%
Cash conversion-139.9%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Life & Health Insurance · cohort 15 companies
Metric7181Activity
Op margin12.3% medp25 5.6% · p75 21.6%
Net margin2.9% medp25 0.5% · p75 10.1%
Gross margin28.2% medp25 13.4% · p75 30.5%
CapEx / revenue-2.1% medp25 -8.2% · p75 -1.2%
Debt / equity12.0%27.5% medp25 4.7% · p75 66.5%below median
Observations
IR observations
Mean price target1,683.33 JPY
Median price target1,683.33 JPY
High price target2,100.00 JPY
Low price target1,163.33 JPY
Mean recommendation2.42 (1=strong buy, 5=strong sell)
Strong-buy count2.00
Buy count3.00
Hold count7.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate145.40 JPY
Last actual EPS107.52 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-01 10:31 UTC#f8328d60
Market quoteclose JPY 1531.00 · shares 1.08B diluted
no public URL
2026-05-01 10:31 UTC#26c64e9d
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 02:50 UTCJob: 5367576c